Evidence map›Paper›PMID 22286159›Full record

Trial reportEuropean journal of clinical pharmacology2012

S-ketamine concentrations are greatly increased by grapefruit juice.

Marko A Peltoniemi, Teijo I Saari, Nora M Hagelberg, Kari Laine, Pertti J Neuvonen, Klaus T Olkkola

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of clinical pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Ketamine Cystitis: An Underrecognized Cause of Dysuria.Journal of general internal medicine · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Marko A PeltoniemiDepartment of Anesthesiology, Intensive Care, Emergency Care and Pain Medicine, University of Turku, Kiinamyllynkatu 4-8, Turku, Finland.
Teijo I Saari
Nora M Hagelberg
Kari Laine
Pertti J Neuvonen
Klaus T Olkkola
Turku University Hospital · FIUniversity of Turku · FIFriedrich-Alexander-Universität Erlangen-Nürnberg · DEUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe examined the effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of oral S-ketamine.

methodsA randomized crossover open-label study design with two phases at an interval of 4 weeks was conducted in 12 healthy volunteers. Grapefruit juice or water was ingested 200 ml t.i.d. for 5 days. An oral dose of 0.2 mg/kg of S-ketamine was ingested on day 5 with 150 ml grapefruit juice or water. Plasma concentrations of ketamine and norketamine were determined for 24 h, and pharmacodynamic variables were recorded for 12 h. Noncompartmental methods were used to calculate pharmacokinetic parameters.

resultsGrapefruit juice increased the geometric mean value of the area under the plasma ketamine concentration-time curve(AUC0-∞) by 3.0-fold (range 2.4- to 3.6-fold; P<0.001), the peak plasma concentration (Cmax) by 2.1-fold (range 1.8- to 2.6-fold; P<0.001), and the elimination half-life by 24% (P<0.05) as compared to the water phase. The ratio of main metabolite norketamine to ketamine (AUCm/AUCp) was decreased by 57% (P<0.001) during the grapefruit phase.Self-rated relaxation was decreased (P<0.05) and the performance in the digit symbol substitution test was increased (P<0.05) after grapefruit juice, but other behavioral or analgesic effects were not affected.

conclusionsGrapefruit juice significantly increased the plasma concentrations of oral ketamine in healthy volunteers.Dose reductions of ketamine should be considered when using oral ketamine concomitantly with grapefruit juice.

Indexed as

BeveragesCitrus paradisiFood-Drug InteractionsAdultAgedAryl Hydrocarbon HydroxylasesCross-Over StudiesCytochrome P-450 CYP2B6Cytochrome P-450 CYP3AFemaleHumansKetamineMaleMiddle AgedOxidoreductases, N-DemethylatingYoung AdultAryl Hydrocarbon HydroxylasesCYP2B6 protein, humanCYP3A protein, humanCytochrome P-450 CYP2B6Cytochrome P-450 CYP3AKetaminenorketamineOxidoreductases, N-Demethylating

Identifiers

PMID22286159
OpenAlexW1981824535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.